CONGRESS ABSTRACT

Introduction: The expected response to iPCSK9 therapy in terms of LDL-C reduction is around 60% in monotherapy. In this clinical case we present an example of hyporesponse to therapy with monoclonal antibody (alirocumab) used in monotherapy. Presentation of the case: Patient F, 77 years old, hospitalized in march 2018 for lateral…

A 76-year-old man comes to our attention transported by 118 for an episode of a fall to the ground with loss of consciousness, undergoing cardiac massage and defibrillation.  The ECG shows extensive signs of necrosis in the anterior region. The echocardiogram shows a left ventricle with a large apical…